[go: up one dir, main page]

MA28740B1 - Methodes de traitement d'infections endobronchiques - Google Patents

Methodes de traitement d'infections endobronchiques

Info

Publication number
MA28740B1
MA28740B1 MA29618A MA29618A MA28740B1 MA 28740 B1 MA28740 B1 MA 28740B1 MA 29618 A MA29618 A MA 29618A MA 29618 A MA29618 A MA 29618A MA 28740 B1 MA28740 B1 MA 28740B1
Authority
MA
Morocco
Prior art keywords
treating
methods
endobronic
infections
patient
Prior art date
Application number
MA29618A
Other languages
English (en)
Inventor
Peter Challoner
Carlos Rodriguez
Thomas E Tarara
John D Lord
Original Assignee
Novartis Vaccines & Diagnostic
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic, Nektar Therapeutics filed Critical Novartis Vaccines & Diagnostic
Publication of MA28740B1 publication Critical patent/MA28740B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des méthodes de traitement d'une infection endobronchique chez un patient par administration, dans le système endobronchique du patient, d'une composition sous forme d'aérosol de poudre sèche comprenant entre 90 et 130 mg d'un antibiotique aminoglycoside, une à trois fois par jour pendant une première période de traitement de 20 à 36 jours.
MA29618A 2004-06-18 2007-01-17 Methodes de traitement d'infections endobronchiques MA28740B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18

Publications (1)

Publication Number Publication Date
MA28740B1 true MA28740B1 (fr) 2007-07-02

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29618A MA28740B1 (fr) 2004-06-18 2007-01-17 Methodes de traitement d'infections endobronchiques

Country Status (25)

Country Link
US (3) US20080214481A1 (fr)
EP (1) EP1765288B1 (fr)
JP (3) JP2008503500A (fr)
KR (2) KR20070026604A (fr)
CN (1) CN101014320B (fr)
AU (1) AU2005258078B2 (fr)
BR (1) BRPI0512146A (fr)
CA (1) CA2570976C (fr)
DK (1) DK1765288T3 (fr)
EC (1) ECSP077182A (fr)
ES (1) ES2399279T3 (fr)
HR (1) HRP20130076T1 (fr)
IL (1) IL179873A (fr)
MA (1) MA28740B1 (fr)
MX (1) MXPA06014567A (fr)
NO (1) NO338799B1 (fr)
NZ (1) NZ552047A (fr)
PL (1) PL1765288T3 (fr)
PT (1) PT1765288E (fr)
RU (1) RU2389477C2 (fr)
SG (1) SG153833A1 (fr)
SI (1) SI1765288T1 (fr)
TN (1) TNSN06420A1 (fr)
WO (1) WO2006002178A1 (fr)
ZA (1) ZA200700420B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364636T3 (es) * 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
ES2666276T3 (es) * 2006-10-11 2018-05-03 Laboratoires Smb Sa Composición farmacéutica antiinfecciosa para inhalación
EP1938822A1 (fr) * 2006-12-21 2008-07-02 Novartis AG Thérapie combinée pour le traitement des maladies des voies respiratoires
CA2724009C (fr) * 2008-05-15 2016-10-11 Novartis Ag Administration pulmonaire d'une fluoroquinolone
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP3106149B1 (fr) 2009-05-29 2019-11-20 Pearl Therapeutics, Inc. Compositions pour l'administration par voie pulmonaire d'antagonistes muscariniques et agonistes du récepteur adrénergique béta-2 à action prolongée, procédés et systèmes associés
WO2011025549A1 (fr) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Dispositifs et procédés médicaux
PH12012501064B1 (en) * 2009-12-14 2017-09-27 Chiesi Farm Spa Antibiotic microparticles for inhalation
JP2013523217A (ja) 2010-03-24 2013-06-17 アボット ダイアベティス ケア インコーポレイテッド 医療用装置挿入器、並びに医療用装置の挿入方法および使用方法
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
MX2014000540A (es) 2011-07-12 2014-05-01 Cardeas Pharma Corp Formulaciones de combinaciones de amecacina y forsfomicina y metodos y sistemas para el tratamiento de neumonia asociada a ventilacion mecanica (vap) y traqueobronquitis asociada a ventilacion mecanica (vat).
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
LT4056105T (lt) 2011-12-11 2024-01-10 Abbott Diabetes Care, Inc. Analitės jutiklių įrenginiai
WO2014055456A1 (fr) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Indicateurs d'introduction de dispositif médical
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
BR112015022784B1 (pt) 2013-03-15 2023-02-14 Pearl Therapeutics, Inc Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
AU2016260547B2 (en) 2015-05-14 2020-09-03 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
CN110461217B (zh) 2017-01-23 2022-09-16 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
WO2020163416A1 (fr) * 2019-02-05 2020-08-13 Mylan Inc Dispositifs et procédés de traitement par inhalation de tobramycine
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CN115942909A (zh) 2020-08-31 2023-04-07 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
FR2224175B1 (fr) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
EP0940154B1 (fr) 1991-07-02 2007-04-18 Nektar Therapeutics Dispositif pour administrer des aérosols de médicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
AU696387B2 (en) 1994-05-18 1998-09-10 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
CN1318104C (zh) 1994-09-21 2007-05-30 耐科塔医药公司 送料管组件
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
ATE287703T1 (de) 1995-04-14 2005-02-15 Nektar Therapeutics Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
BR9911072A (pt) * 1998-05-27 2001-02-06 Euro Celtique Sa Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
CN1348377A (zh) * 1998-12-17 2002-05-08 希龙公司 用气溶胶化的抗生素治疗严重慢性支气管炎(支气管扩张症)的方法
WO2001013891A2 (fr) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation de liberation a partir de formulations seches en poudre
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
ES2261735T3 (es) 2001-05-18 2006-11-16 Chiron Corporation Sistema para la administracion de una formulacion de tobramicina.
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
AU2002340481B2 (en) 2001-11-14 2008-07-17 Novartis Ag Aerosolization apparatus comprising connectable body and endpiece
WO2003041777A1 (fr) 2001-11-14 2003-05-22 Nektar Therapeutics Dispositif a aerosol comprenant un embout de raccordement ameliore
ES2364636T3 (es) * 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
EP1458630A1 (fr) 2001-12-21 2004-09-22 Nektar Therapeutics Emballage a capsules a membrane etanche
CA2483914A1 (fr) 2002-05-07 2003-11-20 Nektar Therapeutics Capsules pour inhalateurs a poudre seche et procedes de fabrication et d'utilisation correspondants
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Also Published As

Publication number Publication date
DK1765288T3 (da) 2013-02-11
MXPA06014567A (es) 2007-07-24
US20110097412A1 (en) 2011-04-28
ZA200700420B (en) 2008-05-28
CA2570976A1 (fr) 2006-01-05
PL1765288T3 (pl) 2013-04-30
IL179873A (en) 2014-09-30
NO20070253L (no) 2007-03-13
TNSN06420A1 (en) 2008-02-22
JP2013056947A (ja) 2013-03-28
JP2012107047A (ja) 2012-06-07
HRP20130076T1 (hr) 2013-03-31
IL179873A0 (en) 2007-05-15
BRPI0512146A (pt) 2008-02-12
CN101014320A (zh) 2007-08-08
ECSP077182A (es) 2007-05-30
NO338799B1 (no) 2016-10-24
WO2006002178A1 (fr) 2006-01-05
US20080214481A1 (en) 2008-09-04
US8664187B2 (en) 2014-03-04
ES2399279T3 (es) 2013-03-27
EP1765288B1 (fr) 2012-11-07
EP1765288A4 (fr) 2009-05-13
CN101014320B (zh) 2011-05-18
RU2389477C2 (ru) 2010-05-20
JP2008503500A (ja) 2008-02-07
NZ552047A (en) 2009-11-27
SI1765288T1 (sl) 2013-02-28
EP1765288A1 (fr) 2007-03-28
KR20070026604A (ko) 2007-03-08
PT1765288E (pt) 2013-01-29
SG153833A1 (en) 2009-07-29
KR20120131245A (ko) 2012-12-04
AU2005258078A1 (en) 2006-01-05
RU2007101906A (ru) 2008-07-27
AU2005258078B2 (en) 2010-09-30
CA2570976C (fr) 2013-08-13
US20120148641A1 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
MA28740B1 (fr) Methodes de traitement d'infections endobronchiques
MA29346B1 (fr) Formulations pharmaceutiques gastrorésistantes à base de rifaximine
WO2001092288A3 (fr) Composes de cobalamine utilises comme agents antibiotiques et comme agents d'imagerie
TNSN08194A1 (fr) Compositions pharmaceutiques solides contenant de la pregabaline
SG170119A1 (en) Nutritional composition comprising indigestible oligosaccharides
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
NO20076219L (no) Farmasoytisk formulering med apomorfin for bukkal administrering
FR2700117B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
MA27059A1 (fr) Azithromycine en dose unique
Finch et al. Antimicrobial chemotherapy
WO2006072940A3 (fr) Preparation pharmaceutique a liberation prolongee et controlee destinee a etre utilisee dans la cavite buccale
BR0011845A (pt) Complexo farmacêutico
MD2211F1 (en) Remedy for treatment of parodontium affections
TNSN00211A1 (fr) Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation
BR0112035A (pt) peptìdeos antimicrobianos de novispirin
EA200400691A1 (ru) Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства
MA29813B1 (fr) Combinaisons pharmaceutiques contenant de la lamivudine, de la stavudine et de la nevirapine
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény
CY1113562T1 (el) Σκευασματα τομπραμυκινης για τη θεραπεια ενδοβρογχικων λοιμωξεων
AU2001250722A1 (en) Medicament for the treatment of diseases caused by parasitic protozoa
EP1758922B8 (fr) Substance peptidique permettant de retablir la fonction des organes respiratoires
WO2003096987A9 (fr) Compositions et leurs methodes d'utilisation destinees au diagnostic et au traitement d'une maladie infectieuse